(800) 526-OPYS Pay my bill Member login
logo
OPYS 10 years
  • Hospital Solutions
    • Emergency Medicine
    • Hospital Medicine
    • Telemedicine
    • Urgent Care
    • Post Acute Care
    • Correctional Medicine
    • Locum Tenens
  • Join our Team
    • Physicians
    • Advanced Practitioners
    • Career Opportunities
  • About OPYS
    • Experienced Group
    • Metrics & Outcomes
    • Throughout the US
    • Quality Patient Care
    • Clinical Performance
    • Qualified Providers
    • Company Profile
    • Leadership Team
    • Mission Statement
    • Reviews
  • News
  • Contact Us

ACE Inhibitors Do Not Seem to Interact With COVID-19

Home > COVID-19 > ACE Inhibitors Do Not Seem to Interact With COVID-19

ACE Inhibitors Do Not Seem to Interact With COVID-19

July 19, 2020

Given the discovery that the angiotensin-converting enzyme 2 (ACE-2) – a key protein in the renin-angiotensin system – is the receptor through which SARS-CoV-2 enters cells, physicians and scientists have been concerned that patients taking ACE inhibitors may be more vulnerable to COVID-19. A study was therefore undertaken to investigate any relationship between COVID-19 infection and the use of ACE inhibitors, which are antihypertensive medicines. The results have now been published in the New England Journal of Medicine.

The observational study included more than 12,500 patients who had tested positive for COVID-19 in New York City.  The authors considered whether these patients had been previously treated with any of the five common classes of medications that fight hypertension, including ACE Inhibitors, ARBs, beta blockers, calcium-channel blockers, and thiazide diuretics.

Nearly half of the patients included in the study – 5,894, or 46.8% – tested positive for COVID-19, and 17% of these infected patients had severe illness. Nearly 60% of the 4,357 patients who had a history of hypertension also tested positive for COVID-19. However, the authors found that compared to people not taking medications that act on the renin-angiotensin-aldosterone system, those taking such medications were no more likely to become infected with COVID-19 or to suffer severe illness once infected with the virus.

While more research is needed to determine if and how medications like ACE inhibitors may interact with COVID-19 risk and outcomes, this study provides data that are promising for those taking antihypertensive medications. These and future results will likely also enable physicians who are sensitive to risks around COVID-19 help their patients understand the best way to treat their conditions while also safeguarding themselves from COVID-19 or other dangerous infections.

 

 

Reference

Reynolds, H.R. (2020). Renin-angiotensin-aldosterone system inhibitors and risk of COVID-19. The New England Journal of Medicine, 382, 2441-2448.

Filed Under: COVID-19, Emergency Physicians, General, Physician Services News, Public Health Tagged With: Coronavirus, COVID-19, Health care, Hospital Physician, Hospital Physicians, Outsourced Physician Services, patient care, Symptoms of coronavirus

Search

Categories

  • Best Practice
  • Cardiologists
  • COVID-19
  • Emergency Physicians
  • General
  • Health Technology
  • Hospital Physicians
  • Hospitalists
  • New Job Opportunities
  • Nurses
  • Patient Care
  • Physician Job
  • Physician Services News
  • Public Health
  • Reimbursement
  • Telehealth Blog Series
  • Women's Health

Archives

  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • April 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • September 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • December 2017
  • March 2017
  • June 2016
  • August 2015
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011

We’d Love to Hear From You,
Get In Touch With Us!

logo

Since 2012, providing quality, efficient, patient-centered healthcare through experienced medical leadership, communication, and collaboration in the provision of hospital-based physician outsourcing services.

Our Services
  • Emergency Medicine
  • Hospital Medicine
  • Telemedicine
  • Urgent Care
  • Post Acute Care
  • Correctional Medicine
OPYS Advantage
  • Our Team
  • Investor Relations
  • Career Opportunities
Contact
Corporate Office 

One Indiana Square, Suite 2060
Indianapolis, IN 46204

Phone: (800) 526-6797
Fax: (800) 456-6148
Email: info@opys.com

Copyright © 2012 - 2022. All rights reserved I Site Map I Privacy Policy I Terms and Use